tirzepatide 中国 分析师预测礼来Tirzepatide 2030年收入264亿美元医药新闻-ByDrug-一站式医药资源共享中心-医药魔方 市值近6000亿美元！礼来Zepbound（tirzepatide）新适应症获美国FDA批准医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

Practical Guidance: Timing, Tolerability, and Follow-Up Combination pharmacotherapy should start simply and change slowly

However, while same-time administration is not mandatory, selecting a consistent day of the week is important

Could become the largest drug class over time Semaglutide going generic improves affordability Prices likely to fall 50 to 70% over time - Even with just 5 to 10% diabetes patient penetration: India GLP-1 market = 7,000 to 8,000 Cr 6 Where Risk-Reward Looks Better

In South Africa, regulators have been stepping up efforts to monitor and regulate the compounded-drug market amid strong demand for lower-cost treatments

Oral liquids and drops GLP-1 oral liquids still require temperature control